CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomas

被引:38
作者
Luo, Robert F. [1 ]
Zhao, Shuchun [1 ]
Tibshirani, Robert [2 ]
Myklebust, June H. [3 ]
Sanyal, Mrinmoy [3 ]
Fernandez, Rosemary [3 ]
Gratzinger, Dita [1 ]
Marinelli, Robert J. [4 ]
Lu, Zhi Shun [1 ]
Wong, Anna [1 ]
Levy, Ronald [3 ]
Levy, Shoshana [3 ]
Natkunam, Yasodha [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Hlth Res & Policy & Stat, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Div Oncol, Dept Med, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA
关键词
CD81; Lymphoma; Tissue microarray; HEPATITIS-C-VIRUS; CHEMOTHERAPY PLUS RITUXIMAB; TISSUE MICROARRAY; TETRASPANIN CD81; T-LYMPHOCYTES; CHOP; SURVIVAL; GENE; IMMUNOHISTOCHEMISTRY; PREDICTION;
D O I
10.1016/j.humpath.2009.07.022
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
CD81 is a tetraspanin cell surface protein that regulates CD19 expression in B lymphocytes and enables hepatitis C virus infection of human cells. Immunohistologic analysis in normal hematopoietic tissue showed strong staining for CD81 in normal germinal center B cells, a cell type in which its increased expression has not been previously recognized. High-dimensional flow cytometry analysis of normal hematopoietic tissue confirmed that among B- and T-cell subsets, germinal center B cells showed the highest level of CD81 expression. In more than 800 neoplastic tissue samples, its expression was also found in most non-Hodgkin lymphomas. Staining for CD81 was rarely seen in multiple myeloma, Hodgkin lymphoma, or myeloid leukemia. In hierarchical cluster analysis of diffuse large B-cell lymphoma, staining for CD81 was most similar to other germinal center B cell associated markers, particularly LMO2. By flow cytometry, CD81 was expressed in diffuse large B-cell lymphoma cells independent of the presence or absence of CD10, another germinal center B-cell marker. The detection of CD81 in routine biopsy samples and its differential expression in lymphoma subtypes, particularly diffuse large B-cell lymphoma, warrant further study to assess CD81 expression and its role in the risk stratification of patients with diffuse large B-cell lymphoma. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:271 / 280
页数:10
相关论文
共 33 条
[1]   Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling [J].
Alizadeh, AA ;
Eisen, MB ;
Davis, RE ;
Ma, C ;
Lossos, IS ;
Rosenwald, A ;
Boldrick, JG ;
Sabet, H ;
Tran, T ;
Yu, X ;
Powell, JI ;
Yang, LM ;
Marti, GE ;
Moore, T ;
Hudson, J ;
Lu, LS ;
Lewis, DB ;
Tibshirani, R ;
Sherlock, G ;
Chan, WC ;
Greiner, TC ;
Weisenburger, DD ;
Armitage, JO ;
Warnke, R ;
Levy, R ;
Wilson, W ;
Grever, MR ;
Byrd, JC ;
Botstein, D ;
Brown, PO ;
Staudt, LM .
NATURE, 2000, 403 (6769) :503-511
[2]   Semi-supervised methods to predict patient survival from gene expression data [J].
Bair, E ;
Tibshirani, R .
PLOS BIOLOGY, 2004, 2 (04) :511-522
[3]   CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. [J].
Coiffier, B ;
Lepage, E ;
Brière, J ;
Herbrecht, R ;
Tilly, H ;
Bouabdallah, R ;
Morel, P ;
Van den Neste, E ;
Salles, G ;
Gaulard, P ;
Reyes, F ;
Gisselbrecht, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (04) :235-242
[4]   Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma [J].
Habermann, Thomas M. ;
Weller, Edie A. ;
Morrison, Vicki A. ;
Gascoyne, Randy D. ;
Cassileth, Peter A. ;
Cohn, Jeffrey B. ;
Dakhil, Shaker R. ;
Woda, Bruce ;
Fisher, Richard I. ;
Peterson, Bruce A. ;
Horning, Sandra J. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (19) :3121-3127
[5]   Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray [J].
Hans, CP ;
Weisenburger, DD ;
Greiner, TC ;
Gascoyne, RD ;
Delabie, J ;
Ott, G ;
Müller-Hermelink, HK ;
Campo, E ;
Braziel, RM ;
Jaffe, ES ;
Pan, ZG ;
Farinha, P ;
Smith, LM ;
Falini, B ;
Banham, AH ;
Rosenwald, A ;
Staudt, LM ;
Connors, JM ;
Armitage, JO ;
Chan, WC .
BLOOD, 2004, 103 (01) :275-282
[6]   A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling [J].
Hummel, Michael ;
Bentink, Stefan ;
Berger, Hilmar ;
Klapper, Wolfram ;
Wessendorf, Swen ;
Barth, Thomas F. E. ;
Bernd, Heinz-Wolfram ;
Cogliatti, Sergio B. ;
Dierlamm, Judith ;
Feller, Alfred C. ;
Hansmann, Martin-Leo ;
Haralambieva, Eugenia ;
Harder, Lana ;
Hasenclever, Dirk ;
Kuehn, Michael ;
Lenze, Dido ;
Lichter, Peter ;
Ignacio Martin-Subero, Jose ;
Moeller, Peter ;
Mueller-Hermelink, Hans-Konrad ;
Ott, German ;
Parwaresch, Reza M. ;
Pott, Christiane ;
Rosenwald, Andreas ;
Rosolowski, Maciej ;
Schwaenen, Carsten ;
Stuerzenhofecker, Benjamin ;
Szczepanowski, Monika ;
Trautmann, Heiko ;
Wacker, Hans-Heinrich ;
Spang, Rainer ;
Loeffler, Markus ;
Truemper, Lorenz ;
Stein, Harald ;
Siebert, Reiner .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (23) :2419-2430
[7]   The tetraspanin web modulates immune-signalling complexes [J].
Levy, S ;
Shoham, T .
NATURE REVIEWS IMMUNOLOGY, 2005, 5 (02) :136-148
[8]   Prognostic biomarkers in diffuse large B-cell lymphoma [J].
Lossos, IS ;
Morgensztern, D .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (06) :995-1007
[9]   Prediction of survival in diffuse large-B-cell lymphoma based on the expression of six genes [J].
Lossos, IS ;
Czerwinski, DK ;
Alizadeh, AA ;
Wechser, MA ;
Tibshirani, R ;
Botstein, D ;
Levy, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (18) :1828-1837
[10]   Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells [J].
Machida, K ;
Cheng, KTH ;
Pavio, N ;
Sung, VMH ;
Lai, MMC .
JOURNAL OF VIROLOGY, 2005, 79 (13) :8079-8089